Aberdeen Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $6.62M | Sell |
13,472
-1,045
| -7% | -$513K | 0.02% | 419 |
|
|
2017
Q1 | $5.63M | Buy |
14,517
+1,354
| +10% | +$525K | 0.02% | 436 |
|
|
2016
Q4 | $4.83M | Sell |
13,163
-946
| -7% | -$347K | 0.02% | 445 |
|
|
2016
Q3 | $5.67M | Sell |
14,109
-290
| -2% | -$117K | 0.02% | 416 |
|
|
2016
Q2 | $5.03M | Sell |
14,399
-1,627
| -10% | -$568K | 0.02% | 420 |
|
|
2016
Q1 | $5.78M | Sell |
16,026
-3,404
| -18% | -$1.23M | 0.02% | 391 |
|
|
2015
Q4 | $10.2M | Buy |
19,430
+2,666
| +16% | +$1.4M | 0.03% | 291 |
|
|
2015
Q3 | $7.8M | Sell |
16,764
-1,079
| -6% | -$502K | 0.03% | 305 |
|
|
2015
Q2 | $9.1M | Sell |
17,843
-953
| -5% | -$486K | 0.03% | 280 |
|
|
2015
Q1 | $8.49M | Sell |
18,796
-14,088
| -43% | -$6.36M | 0.02% | 279 |
|
|
2014
Q4 | $13.5M | Sell |
32,884
-17,537
| -35% | -$7.19M | 0.03% | 228 |
|
|
2014
Q3 | $18.2M | Buy |
50,421
+20,488
| +68% | +$7.39M | 0.04% | 222 |
|
|
2014
Q2 | $8.46M | Buy |
29,933
+21,533
| +256% | +$6.08M | 0.02% | 359 |
|
|
2014
Q1 | $2.52M | Hold |
8,400
| – | – | 0.01% | 301 |
|
|
2013
Q4 | $2.29M | Hold |
8,400
| – | – | 0.01% | 290 |
|
|
2013
Q3 | $2.63M | Sell |
8,400
-200
| -2% | -$62.6K | 0.01% | 251 |
|
|
2013
Q2 | $1.93M | Buy |
+8,600
| New | +$1.93M | 0.01% | 304 |
|